IP Library Granted Patent US 11,371,000
Granted Patent B2
US 11,371,000 · App. 15/474,214 · Granted Jun 28, 2022

Devices, systems and methods for inhibiting invasion and metastases of cancer

Inventors: Geraldine A Hamilton (Boston, MA); Norman Wen (West Roxbury, MA); Catherine Karalis (Brookline, MA); Antonio Varone (West Roxbury, MA); Daniel Levner (Brookline, MA); Riccardo Barrile (Boston, MA)
Assignee: EMULATE, INC.
C12M23/16C12M25/02C12N5/0693G01N33/5011G01N33/5017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,371,000
App. No.
15/474,214
Granted
Jun 28, 2022
Kind
B2
Abstract

The invention generally relates to a microfluidic platforms or “chips” for testing and understanding cancer, and, more specifically, for understanding the factors that contribute to cancer invading tissues and causing metastases. Tumor cells are grown on microfluidic devices with other non-cancerous tissues under conditions that simulate tumor invasion. The interaction with immune cells can be tested to inhibit this activity by linking a cancer chip to a lymph chip.

Claims (18)

1. A method comprising:

1) providing

a) a microfluidic device comprising:

a body having a first channel and a first chamber, an at least partially porous membrane positioned at an interface region between the first channel and the first chamber, the membrane comprising a top surface and a bottom surface, said top surface facing the first chamber;

living epithelial cells disposed within the first chamber as a layer of cells; and

living tumor cells in contact with said living epithelial cells, said tumor cells originating from a biopsy, and disposed within at least one of the first chamber or the first channel; and

2) testing said epithelial cell layer for invasion by said tumor cells.

2. The method of claim 1 , wherein the first chamber comprises a second channel.

3. The method of claim 1 , wherein the first chamber comprises an open region.

4. The method of claim 1 , wherein said tumor cells comprise melanoma cells.

5. The method of claim 1 , wherein the method further comprises endothelial cells disposed within the first channel.

6. A method comprising:

1) providing

a) a microfluidic device comprising a body having a first chamber, an at least partially porous membrane comprising a top surface and a bottom surface, said top surface facing the first chamber;

b) living epithelial cells disposed within the first chamber as a layer of cells; and

c) living tumor cells in contact with said living epithelial cells, and disposed within said first chamber; and

2) testing said epithelial cell layer for invasion by said tumor cells.

7. The method of claim 6 , wherein said tumor cells comprise melanoma cells.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2018
From: HAMILTON, GERALDINE A.; WEN, NORMAN; KARALIS, CATHERINE; VARONE, ANTONIO; LEVNER, DANIEL; BARRILE, RICCARDO
To: EMULATE, INC.
Reel/Frame 045510/0968 →
Continuity (2)
Provisional Application 62315401 · Mar 30, 2016
Related Publication 20170285003A1 · Oct 5, 2017